Fate Therapeutics Announces Encore Clinical Data Presentation of FT819 Off-the-Shelf CAR T-Cell Product Candidate at the CCR – West 2026 Meeting
Go back to Fate Therapeutics Announces Encore Clinical Data Presentation of FT819 Off-the-Shelf CAR T-Cell Product Candidate at the CCR – West 2026 Meeting| FATE THERAPEUTICS (NASDAQ: FATE) | Delayed: 2.50 -0.03 (1.19%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $2.53 | 52 Week High | $4.76 | |||
| Open | $2.52 | 52 Week Low | $1.46 | |||
| Day High | $2.58 | P/E | N/A | |||
| Day Low | $2.44 | EPS | $-1.91 | |||
| Volume | 720,528 | |||||
